| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 250.89M | 190.89M | 180.88M | 179.09M | 246.44M | 160.87M |
| Gross Profit | 25.89M | 21.30M | 22.44M | 23.75M | 28.36M | 18.41M |
| EBITDA | 175.00K | 2.60M | 16.92M | 9.70M | 15.99M | 7.19M |
| Net Income | -6.09M | -3.24M | 7.75M | 5.02M | 9.99M | 3.25M |
Balance Sheet | ||||||
| Total Assets | 179.21M | 137.75M | 153.94M | 156.96M | 114.77M | 110.57M |
| Cash, Cash Equivalents and Short-Term Investments | 21.22M | 11.20M | 12.97M | 5.53M | 6.61M | 6.82M |
| Total Debt | 55.94M | 55.25M | 71.58M | 75.14M | 44.30M | 49.03M |
| Total Liabilities | 77.26M | 66.33M | 81.94M | 93.11M | 55.92M | 61.72M |
| Stockholders Equity | 99.40M | 70.86M | 71.61M | 63.85M | 58.83M | 48.84M |
Cash Flow | ||||||
| Free Cash Flow | -11.37M | 11.57M | 4.49M | -34.30M | 5.10M | 3.66M |
| Operating Cash Flow | 1.87M | 16.45M | 16.25M | -13.51M | 10.49M | 5.68M |
| Investing Cash Flow | -7.82M | 575.00K | -2.44M | -17.72M | -4.72M | -1.28M |
| Financing Cash Flow | 18.55M | -18.80M | -6.36M | 30.15M | -5.98M | -7.24M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
52 Neutral | HK$1.43B | -0.25 | ― | ― | -9.07% | -26.94% | |
51 Neutral | HK$3.66B | ― | -8.58% | ― | 71.00% | -579.14% | |
47 Neutral | $3.17B | -0.92 | -26.57% | 8.89% | -13.69% | -1296.59% | |
45 Neutral | $2.30B | -0.70 | -87.36% | 3.15% | -14.04% | -4222.02% | |
45 Neutral | HK$1.27B | ― | -4.42% | 4.25% | 11.33% | 56.94% | |
45 Neutral | HK$153.00M | ― | -8.81% | ― | -24.42% | -115.68% |
Guan Chao Holdings Limited announced a change in its auditing firm, with PricewaterhouseCoopers resigning due to a disagreement over audit fees for the financial year ending December 31, 2025. The company has appointed ZHONGHUI ANDA CPA Limited as the new auditor, effective November 21, 2025, after a thorough evaluation by the Audit Committee. This transition is not expected to impact the preparation of the company’s consolidated financial statements.
Guan Chao Holdings Limited announced that its subsidiary, GROLAND Inc., has successfully obtained a Certificate of Cosmetic Product Listing from Zoop Technical Service for its ‘Groland AquaKine Scalp Serum.’ This certification, in compliance with the FDA’s Modernization of Cosmetics Regulation Act of 2022, allows the product to enter the U.S. market. The registration of active compounds XTP-118 and XTP-016 further strengthens the company’s market positioning, enabling safe and compliant product offerings. This milestone not only enhances the company’s ability to promote its brand but also lays the groundwork for future global expansion.
Guan Chao Holdings Limited announced that its subsidiary, Guangzhou Jinghong, has been included in the list of technology-based small and medium-sized enterprises (SMEs) by the Department of Science and Technology of Guangdong Province. This inclusion is expected to provide the company with access to beneficial policies such as tax incentives and financial subsidies, enhancing its market competitiveness and supporting its development plans.
Guan Chao Holdings Limited has announced the composition of its board of directors and the roles within its three board committees. The board includes executive, non-executive, and independent non-executive directors, with specific members assigned to the audit, remuneration, and nomination committees. This announcement reflects the company’s commitment to maintaining a structured governance framework, which is crucial for its operational integrity and stakeholder confidence.
Guan Chao Holdings Limited has announced changes in its board composition, effective from October 21, 2025. Ms. Ng Hui Bin Audrey has resigned as an executive director to focus on other commitments, while Ms. Dong Wenying has been appointed as a non-executive director. Ms. Dong brings significant experience in the financial sector, particularly in private equity and venture capital investments, which may enhance the company’s strategic decision-making and investment capabilities.